The current paradigm to strive to diagnose and treat diseases early and effectively remains unquestionable. However, COVID-19 has challenged this central dogma and left us with an unparalleled growing global healthcare crisis. Reports are clear that the pandemic is creating numerous ripple effects for patients who are facing delays to both the diagnosis and treatment […]
The spread of COVID-19 has affected every industry, every facet of life. But its impact on healthcare providers is significantly higher than most and continues to create a ripple effect of significant burdens. Not only are healthcare workers experiencing grave challenges at work, but their concerns and worries extend home to their family members. Heathcare […]
Our mental health has taken a beating this year. One of many ripple effects from COVID-19 is the toll that living through a pandemic has taken on people’s emotional, psychological and social wellbeing. Whether it’s stress from the blurring boundaries between work and home life, a sense of longing from not being able to see […]
Remember when global singer-songwriter Ed Sheeran announced he was quitting social media? He bade farewell to his 16 million Twitter followers, dumped his phone and spent months jetting around the world. That decision, five years ago, was perceived as unusual and even foolish. Quickly though, as if permission had been granted, going tech-free became on-trend. […]
The pandemic in which we are currently living has seen many of us just about surviving, and certainly not thriving. The impact of COVID-19 has been far reaching and touched upon every aspect of our lives; the way we work, the way we socialize, the way we interact with our families. Unsurprisingly, there is a […]
A broad number of trends and issues have been accelerated or exposed by COVID-19. One of them is the matter of health literacy. Even in developed countries with high levels of general education, such as the US or the UK, there is marked variability in the understanding of information about health. At the same time, […]
The financial impact of the COVID-19 pandemic presents a potential risk to the future of clinical trials in rare diseases. Rare diseases by their nature are not very prevalent in the population, therefore, any treatment for a rare disease will only have a small number of beneficiaries. In addition, so-called orphan drug development takes around 18% […]
With reduced capacity and opportunity for fundraising, extra pressure on support services and attention diverted elsewhere, it will take a long time for them to recover and return to business as usual.
Many companies are facing challenging decisions on whether to proceed with clinical trials in the coming months as countries experience varying degrees of lockdown.
Medical congresses – crucial for the presentation of trial data, scientific exchange and the opportunity to engage with medical professionals, patient advocates, media and analysts – have been cancelled, postponed or are moving to virtual/part virtual.